Surgical management of endocrine tumor of the pancreas in Japan |
| |
Authors: | Ryo Hosotani Masafumi Kogire Tadahiro Takada Hiroyuki Kato Takahiko Funabiki Masumasa Horisawa Takeshi Morimoto Takukazu Nagakawa Toshimichi Nakayama Itsuo Miyazaki Masayuki Imamura |
| |
Affiliation: | 1. First Department of Surgery, Kyoto University, 54-Shogoin Kawaracho, Sakyo-ku, 606-01, Kyoto, Japan 2. Second Department of Surgery, Hokkaido University School of Medicine, Hokkaido, Japan 3. Department of Surgery, Fujita Health University School of Medicine, Fujita, Japan 4. Department of Surgery, National Nagoya Hospital, Nagoya, Japan 5. Department of Gastroenterological Surgery, Aichi Cancer Center, Aichi, Japan 6. Second Department of Surgery, School of Medicine, Kanazawa University, Kanazawa, Japan 7. Second Department of Surgery, Kurume University School of Medicine, Kurume, Japan
|
| |
Abstract: | Endocrine tumor of the pancreas is potentially malignant. A multicenter analysis of these tumors was conducted to clarity the present status of their surgical management and the subsequent long-term surgical results. The Japan pancreatoduodenectomy (JPD) study group carried out the study; 368 patients were enrolled and variables related to tumor characteristics, surgery, and survival were retrospectively analyzed. There were 222 patients with functioning tumor and 143 patients with nonfunctioning tumor. Malignant tumor was found in 140 of 368 (38%) of the patients, and 63/140 (45%) of these patients had metastatic lesion; the most common site of the metastasis was liver 34/136 (25%), followed by regional lymph nodes 26/136 (19%). Pancreatic resection was performed in 91% of patients with nonfunctional tumor and in 83% of those with malignant tumor, and 73% of the pancreatic resections were done with lymph node dissection. The overall 5-year actuarial survival rate was 76% in patients with malignant tumor. The actuarial 5-year survival rate was 93% in the patients without metastasis and 83% in patients who received curative resection. Multivariate analysis showed that the presence or absence of synchronous metastasis was the sole significant prognostic factor. The results suggest that: (i) malignant endocrine tumor of the pancreas is a curable malignancy when pancreatic resection with lymph node dissection is adopted and (ii) that synchronous metastasis is the dominant prognostic factor. |
| |
Keywords: | pancreatic resection islet cell carcinoma survival |
本文献已被 SpringerLink 等数据库收录! |
|